A global study Haleon plc commissioned to identify key reasons for health inequality and common barriers consumer face to adopting self-care shows the company has its work cut out for it helping improve “health inclusivity” in the United States.
Haleon, the UK firm spun out earlier in 2022 from GlaxoSmithKline plc with a portfolio comprising the consumer health care lines previously marketed by GSK and Pfizer Inc., on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?